FUJIFILM Diosynth Biotechnologies is a contract development and manufacturing organisation (CDMO) that produces vaccines, gene therapies, and other biologics for pharmaceutical clients. The company operates within FUJIFILM Corporation's broader healthcare segment, which covers diagnostic imaging, endoscopic imaging, medical systems, regenerative medicine, and life sciences. Its technical capabilities include mRNA synthesis, lipid nanoparticle formulation, liposome development, and advanced manufacturing technologies.
The company has a global footprint with operations in Denmark, the United States, and other locations. It is part of an organisation that employs over 70,000 people worldwide and maintains a commitment to powering its sites with 100% renewable energy. The broader FUJIFILM group operates across healthcare, electronics, business innovation, and imaging.
FUJIFILM Diosynth Biotechnologies supports clients from early-stage biopharmaceutical development through to commercial-scale manufacturing, positioning it as a partner for companies advancing novel therapies through clinical trials and into production.
